Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat

Overview of attention for article published in Breast Cancer Research, May 2012

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (76th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 4 X users

wikipedia: 3 Wikipedia pages

Citations

dimensions_citation: 215 Dimensions

Readers on

mendeley: 262 Mendeley
citeulike: 1 CiteULike

Summary X Wikipedia Dimensions citations

So far, Altmetric has seen 3 citations on 3 Wikipedia pages.

Panobinostat

Cited by user Ptthnhan on 17 Aug 2019

パノビノスタット

Cited by user Utataneko on 13 Jul 2015

Panobinostat

Cited by user Papalogan on 01 Aug 2012

Panobinostat (LBH-589, trade name Faridak) is an experimental drug developed by Novartis for the treatment of various cancers.